There are two critical topics at the intersection of the pharmaceutical industry and digital health. The first is how pharmaceutical companies can effectively integrate digital technology to improve treatment plans. The second is addressing the challenges clinical trials face regarding diversity, consent, and stigma. Both topics are essential in improving patient outcomes and advancing medical research. Dr. John Kraus is Otsuka's Executive Vice President and Chief Medical Officer. With over 25 years of experience in clinical, academic, pharmaceutical medicine, and drug development, John's patient-centered approach and dedication to advancing care for underserved patients drive his work at Otsuka. On this episode of The Beat, recorded at ViVE 2023, Dr. Kraus joins hosts Dr. Gautam Gulati and Dr. Jessica Shepherd to explore the importance of integrating digital technology into pharmaceutical drug development and how it can improve patient outcomes. They also discuss the challenges of diversity, consent, and stigma in clinical trials and how Otsuka is working to address them. Dr. Kraus also delves into the challenges faced in clinical trials, particularly in the psychiatric and neurologic space, and the need for improvement in the inclusivity, consent, and monitoring of outcomes. Listen in to learn about the future of pharmaceutical companies and their integration with digital health, and the importance of patient-centered approaches in advancing care.
Topics Covered
Connect with Dr. John Kraus
Connect with Dr. Gautam Gulati & Dr. Jessica ShepherdÂ
Resources